Choline chloride attenuates the allergic airway disease by inhibiting the lysophosphatidylcholine induced response in mouse model.

Bansal P, Singh N, Joshi J, Arora N, Gaur SN

Open source

DOI
10.1016/j.crphar.2022.100109
Published
2022
Container
Current research in pharmacology and drug discovery
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.crphar.2022.100109,
  title = {Choline chloride attenuates the allergic airway disease by inhibiting the lysophosphatidylcholine induced response in mouse model.},
  author = {Bansal P and Singh N and Joshi J and Arora N and Gaur SN},
  year = {2022},
  journal = {Current research in pharmacology and drug discovery},
  doi = {10.1016/j.crphar.2022.100109},
  url = {https://doi.org/10.1016/j.crphar.2022.100109}
}

RIS

TY  - JOUR
TI  - Choline chloride attenuates the allergic airway disease by inhibiting the lysophosphatidylcholine induced response in mouse model.
AU  - Bansal P
AU  - Singh N
AU  - Joshi J
AU  - Arora N
AU  - Gaur SN
PY  - 2022
JO  - Current research in pharmacology and drug discovery
DO  - 10.1016/j.crphar.2022.100109
UR  - https://doi.org/10.1016/j.crphar.2022.100109
ER  - 

APA

P, B., N, S., J, J., N, A., & SN, G. (2022). Choline chloride attenuates the allergic airway disease by inhibiting the lysophosphatidylcholine induced response in mouse model.. Current research in pharmacology and drug discovery. https://doi.org/10.1016/j.crphar.2022.100109

Source records